George M. Lasezkay is CEO at Clearside Biomedical, Inc. (CLSD). They have made 3 open-market trades across 1 company since 2019, most recently 2024-01-19.
CIK 0001020514
1 open-market purchase totalling $14K since 2019, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CLSD | 466,577 | $191K |
Shares reported on the most recent Form 4, priced at the 2024-01-19 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CLSD | SELL | 2024-01-19 | 2024-01-19 | $1.27 | $23K | +0.0% | +3.2% | +5.6% |
| CLSD | SELL · 10b5-1 | 2023-01-19 | 2023-01-20 | $1.46 | $29K | +1.3% | -9.9% | -26.3% |
| CLSD | SELL · 10b5-1 | 2022-01-19 | 2022-01-20 | $2.12 | $23K | +0.0% | -22.6% | -2.1% |
| CLSD | SELL · 10b5-1 | 2022-01-11 | 2022-01-13 | $2.46 | $13K | -19.4% | -26.4% | -6.2% |
| CLSD | SELL · 10b5-1 | 2021-09-21 | 2021-09-23 | $6.46 | $23K | -25.1% | -17.6% | -56.8% |
| CLSD | SELL · 10b5-1 | 2021-06-21 | 2021-06-23 | $4.38 | $16K | +6.5% | -1.3% | +25.2% |
| CLSD | SELL · 10b5-1 | 2021-03-19 | 2021-03-23 | $2.82 | $10K | +5.0% | +23.0% | +88.7% |
| CLSD | SELL · 10b5-1 | 2021-03-02 | 2021-03-03 | $3.37 | $20K | -10.6% | -28.3% | -23.7% |
| CLSD | SELL · 10b5-1 | 2020-12-21 | 2020-12-23 | $2.07 | $7K | +72.5% | +89.5% | +13.5% |
| CLSD | SELL · 10b5-1 | 2020-09-22 | 2020-09-24 | $1.59 | $21K | +1.3% | -12.0% | +34.0% |
| CLSD | SELL | 2020-05-12 | 2020-05-13 | $1.99 | $128K | -6.0% | -8.3% | -19.9% |
| CLSD | BUY | 2019-11-11 | 2019-11-12 | $1.16 | $14K | +4.5% | +57.3% | +163.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.